Clinical Trials
4 trialsNCT06235125 2026-06-05
Cytalux
Ann & Robert H Lurie Children's Hospital of Chicago
Phase 1 Recruiting
NCT07039526 2026-06-05
Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
University of Texas Southwestern Medical Center
Phase 2 Recruiting
NCT06434909 2026-06-01
CYTALUXâ„¢for the Intraoperative Imaging of Prostate Cancer
Indiana University
Phase 2 Completed
NCT06915727 2026-04-01
An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors
Mayo Clinic
Phase 3 Recruiting